mitotane has been researched along with Pigmentary Retinopathy in 1 studies
Mitotane: A derivative of the insecticide DICHLORODIPHENYLDICHLOROETHANE that specifically inhibits cells of the adrenal cortex and their production of hormones. It is used to treat adrenocortical tumors and causes CNS damage, but no bone marrow depression.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ng, WT | 1 |
| Toohey, MG | 1 |
| Mulhall, L | 1 |
| Mackey, DA | 1 |
1 other study available for mitotane and Pigmentary Retinopathy
| Article | Year |
|---|---|
Pigmentary retinopathy, macular oedema, and abnormal ERG with mitotane treatment.
Topics: Adrenal Gland Neoplasms; Adult; Antineoplastic Agents, Hormonal; Electroretinography; Female; Fluore | 2003 |